Scott Saxman

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere et al. · New England Journal of Medicine · 2004 · 3.2K citations

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

Paul B. Chapman, Lawrence H. Einhorn, Michael L. Meyers et al. · Journal of Clinical Oncology · 1999 · 758 citations

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

Edward L. Korn, Ping-Yu Liu, Sandra J. Lee et al. · Journal of Clinical Oncology · 2008 · 695 citations · Full text

Soft tissue sarcomas of adults: state of the translational science.

Ernest C. Borden, Laurence H. Baker, Robert S. Bell et al. · PubMed · 2003 · 616 citations

Single Gene Family, Imatinib Mesylate, Gastrointestinal Oncology +13

Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

Jay S. Cooper, Qiang Zhang, Thomas F. Pajak et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 589 citations · Full text

Long-term Follow-up, Radiation Therapy, Rtog 9501/Intergroup +10